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LETTERS TO THE EDITOR
Figure 1. Histology of resected polyps. Hematoxylin and eosin
stain is shown at 50# (A and C) and 200# (B and D) magnifi-
cation. A, Sessile-peduncolated lesion with features of a typical
juvenile polyp, characterized by large cysts containing mucus. B,
Area with atypical epithelium in the head of the lesion. C, Another
polypoid lesion with features of juvenile polyp. D, Proliferation of
gangliar cells in the lamina propria.
Table 1. BAC Clones Spanning the Region from
10q22 to 10q23 Used in FISH Experiments
BAC Clone
Location
(Mb)
Cytogenetic
Band
FISH
Signals on
Chromosome
10
RP11-119F19 81.0–81.2 10q22.3 /
RP11-773D16 81.4–81.5 10q22.3 /
RP11-479O17 81.6–81.8 10q22.3 /
RP11-40F6 81.91–81.99 10q22.3 /
RP11-36D19 82.0–82.15 10q22.3 Weaker signal
on del(10q)
RP11-93O23 82.16–82.33 10q22.3 /
RP11-175M21 82.4–82.6 10q22.3 /
RP11-102H24 82.8–82.95 10q22.3 /
RP11-202D18 83.8–83.4 10q23.1 /
RP11-156D10 84.5–84.7 10q23.1 /
RP11-99I12 84.7–84.9 10q23.1 /
RP11-124L5 85.8–86.0 10q23.1 /
RP11-134O16 87.6–87.8 10q23.2 /
RP11-96C23 88.7–88.9 10q23.2 /
RP11-79A15 89.4–89.6 10q23.31 /
RP11-380G5 89.6–89.8 10q23.31 /
RP11-106M14 93.3–93.5 10q23.32 /
RP11-74B2 93.9–94.1 10q23.32 /
RP11-61K23 94.0–94.2 10q23.33 /
RP11-366I13 94.2–94.4 10q23.33 /
RP11-469M1 94.4–94.6 10q23.33 Weaker signal
on del(10q)
RP11-148C9 94.6–94.8 10q23.33 /
RP11-280G19 94.8–95.0 10q23.33 /
RP11-162K11 95.7–95.9 10q23.33 /
RP11-30E16 95.2–95.4 10q23.33 /
RP11-146P21 96.0–96.2 10q23.33 /
RP11-208c17 96.6–96.8 10q23.33 /
RP11-248J23 97.6–97.8 10q24.1 /
RP11-34E5 98.2–98.4 10q24.1 /
NOTE.—BAC clones spanning the region from 10q22 to 10q23
used in FISH experiments were selected from the human library
RPCI-11, according to the UCSC Genome Browser (May 2004).
BMPR1A is located between 88.5 and 88.6 Mb, PTEN is located
between 89.6 and 89.7 Mb, and FAS is located at 90.4 Mb.
Deletion of PTEN and BMPR1A
on Chromosome 10q23 Is Not Always
Associated with Juvenile Polyposis of Infancy
To the Editor: We read, with great interest, the report by
Delnatte et al.1 published in the June 2006 issue of The
American Journal of Human Genetics. The authors describe
four patients who presented with a severe form of juve-
nile polyposis of infancy (JPI), with interstitial deletions
of chromosome 10q23 encompassing the BMPR1A and
PTEN genes. The authors hypothesize that this genetic
defect is specific to JPI and that such a severe phenotype
reflects cooperation between these two tumor-suppressor
genes.
We report a patient who had a similar interstitial de-
letion of chromosome 10 that was, however, associated
with a significantly milder phenotype. The patient, an 8-
year-old girl, was born in the 36th gestational week to
nonconsanguineous parents with a family history nega-
tive for JPI. Birth weight was 2,850 g (75th percentile),
length was 50 cm (75th–90th percentile), and head cir-
cumference was 34 cm (50th–75th percentile). Perinatality
and early development were normal. Mild developmental
delay was noticed during the 2nd year of life.
She was first seen at our clinic at age 3 years and 7 mo.
Head circumference was 49 cm (0.5 SD), weight was 14.5
kg (10th–25th percentile), and height was 97.5 cm (50th
percentile). She had mildly dysmorphic features: sparse
hair, epicanthic folds, hypoplastic nasal bone, protruding
lower lip, small ears, and high-arched palate, with normal
tooth development. A single 1.5#1.5–cm cafe´-au-lait spot
on the left thigh was present; no other cutaneous lesions
were noticed.
Heart sonogram revealed a small atrial septal defect. Re-
sults from electroencephalogram, brain magnetic reso-
nance imaging, audiometric tests, and funduscopic ex-
amination were normal. Our patient had never com-
plained of gastrointestinal symptoms, and she did not
have her first episode of mild rectal bleeding until age 5
years. Colonoscopy performed at age 6 years detected mul-
tiple (115) polyps throughout the entire length of the co-
lon. Histology of resected lesions was compatible with ju-
venile polyps, and the largest polyp also had areas of
low-grade focal dysplasia in the head of the lesion (fig. 1).
Upper-gastrointestinal-tract endoscopy and videoendos-
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Figure 2. FISH analysis. Probes RP11-36D19 (A), RP11-74B2 (B), and RP11-469M1 (C) show weaker signals at the breakpoints (A and
C) and absence of signal on del(10) (B). Short arrow p normal chromosome 10; long arrow p del(10).
Table 2. Results of Genotyping of STS Loci in the 10q Region
Locus
Location
(Mb)
Size of PCR Producta
(bp)
ResultProband Mother Father
D10S1730 78.60 234/236 236/250 234/240 Not deleted
D10S219 80.52 86/92 86/92 86/92 Not deleted
D10S1686 85.55 196 182/196 184/194 Paternal allele deleted
D10S1765 89.59 168 168/182 172 Paternal allele deleted
D10S583 94.35 203 203 212 Paternal allele deleted
D10S1709 99.37 158/166 152/166 156/158 Paternal allele deleted
D10S1266 102.31 158.11 158/160 156/158 Uninformative
D10S1741 109.11 250/252 250 248/252 Not deleted
NOTE.—Genotyping of polymorphic loci was performed by amplification with primers
labeled with fluorescent probes, followed by analysis on an ABI 310 Genetic Analyzer
(Applied Biosystems). Nonpolymorphic loci were assayed by electrophoresis on aga-
rose gels (not shown).
a Some cells have two values because the individual is heterozygous for that
particular STS, whereas others have just one value because the individual is either
homozygous or hemizygous at that locus. The comparison with the parents allows
one to distinguish between these last two cases.
copic examination of the small intestine were normal. She
never experienced major bleeding, iron-deficient anemia,
or diarrhea.
A high-resolution karyotype detected an interstitial de-
letion of chromosome 10q23. To define the deletion at
the molecular level, we proceeded with FISH experiments,
using BAC clones spanning the region from 10q22 to
10q23 (table 1 and fig. 2). The final interpretation of the
rearrangement was a 12-Mb deletion from 10q22.3 (BAC
clone RP11-36D19, at 82.1 Mb) to 10q23.3 (BAC clone
RP11-469M1, at 94.4 Mb). We genotyped eight STS loci
in the 10q region of the patient and of her parents. Results
are summarized in table 2. The deletion was de novo and
involved the paternal chromosome. Analysis of the de-
leted region revealed that it contains 87 genes, many still
uncharacterized. BMPR1A, PTEN, and FAS are the most
notable genes involved.
Juvenile polyposis syndrome (MIM 174900) is com-
posed of three main subtypes: JPI, juvenile polyposis coli,
and generalized juvenile polyposis.2 It is still debated
whether these three subtypes represent different clinical
entities or are variants of the same clinical form.3
Delnatte et al.1 suggest that JPI is a contiguous-gene syn-
drome and that the deletion of both PTEN and BMPR1A
is the specific genetic defect of this form. They propose
that these two genes have a synergistic effect on the de-
velopment of this severe phenotype.
The clinical picture of our patient, who harbors a similar
deletion, is remarkably different from those of the four
patients described by Delnatte et al.1 and from that of the
patient described by Tsuchiya et al.,4 all of whom have a
proven deletion of both genes. Our patient did not have
any of the features of JPI (i.e., onset before age 2 years,
severe bleeding, diarrhea, protein-losing enteropathy, in-
anition, and rectal prolapse5), and polyps were found only
in the colon. Three of the four patients reported by Del-
natte et al.1 underwent colectomy at ages 10 mo, 17 mo,
and 8 years because of the severity of symptoms, such as
diarrhea and bleeding. Although our patient is still oli-
gosymptomatic, we are now considering prophylactic co-
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Figure 3. Schematic representation of the 10q22-10q23 deletion in our patient (A), in patients 1 (B) and 2 (C) reported by Delnatte
et al.,1 and in the patient (D) reported by Tsuchiya et al.4
lectomy, because of the foci of dysplasia found in one
polyp. Furthermore, our patient did not display any of
the clinical signs typical of Cowden syndrome (CS [MIM
158350]) or Bannayan-Riley-Ruvalcaba syndrome (MIM
153480)—in particular, she did not have macrocephaly,
cutaneous lesions, or lipomas,6 and only mild and aspe-
cific dysmorphic signs were present. Even though some
of the features of CS, as well as extracolonic polyps, may
appear at a later age, the clinical picture of our patient
underscores the phenotypic variability of 10q23 deletions.
There are several possible explanations for this phenom-
enon. It may reflect the ample phenotypic variability
of PTEN mutations (also intrafamilial), which is well doc-
umented.6 Conversely, a rare haplotype at either the non-
deleted PTEN or BMPR1A locus in our patient might be
associated with a high level of expression of the remaining
allele. Other genetic modifier loci may also play an im-
portant role in determining the phenotype. Our patient
harbored a deletion that extended from 82.1 to 94.4 Mb,
which was larger than those of the patients reported else-
where (fig. 3). The two deletions fully characterized by
Delnatte et al.1 extended from 88.4 to 90.4 Mb (patient
1) and from 88.5 to 90.6 Mb (patient 2), whereas the de-
letion in the patient reported by Tsuchiya et al.4 ranged
from 87.8 to 92.5 Mb. One can speculate that deletion of
one or more genes in the 82.1–87.8-Mb and 92.5–94.4-
Mb regions might contribute to the milder phenotype in
our patient; however, this hypothesis seems unlikely, and
we could not identify any obvious gene with such a role
within these regions. The size of the deletion, however,
may be related to the presence of mild mental retardation.
This feature was present in our patient and in the patient
who harbored larger deletions, reported by Tsuchiya et al.,4
whereas patients 1 and 2 with smaller deletions, reported
by Delnatte et al.,1 had normal intelligence. To clarify
these issues, a larger number of patients must be charac-
terized at the molecular level. Finally, the parental origin
of the deletion does not seem to contribute to the clinical
presentation, since Delnatte et al.1 report both paternal
and maternal deletions in their series of patients with a
severe phenotype.
Variable expressivity is not uncommon for microdele-
tion syndromes. An example is DiGeorge/velocardiofa-
cial syndrome, which is associated with deletions of the
22q11.2 region.7 Patients display a marked clinical vari-
ability, even within the same family.8 This variability is
probably due, in part, to nongenetic factors, as demon-
strated by studies of identical twins.9 The 10q23 micro-
deletions probably behave in a similar fashion.
Interestingly, our patient’s deletion included FAS, a gene
with a pivotal role in regulating apoptosis. Analysis of the
deletion breakpoints of the patient with severe JPI re-
ported by Tsuchiya et al.4 reveals that FAS was also deleted.
Mutations in FAS have been associated with a fatal auto-
somal dominant lymphoproliferative disorder (autoim-
mune lymphoproliferative syndrome [MIM 601859]).10
Our patient did not show any of the early features of this
disorder (i.e., lymphadenomegaly, splenomegaly, hemo-
lytic anemia, and hypergammaglobulinemia), and her im-
mune function is essentially normal. No immune abnor-
malities were reported by Tsuchiya et al. either.4 These data
suggest that FAS haploinsufficiency is not associated with
a specific phenotype and confirm that heterozygous mu-
tations in FAS probably act through a dominant negative
mechanism.10 We are currently evaluating in depth the
immune function of our patient, to unveil minor abnor-
malities of lymphocyte function.
In conclusion, we believe that the phenotypic spectrum
of the deletion of both PTEN and BMPR1A is not restricted
to JPI and that further clinical and experimental data are
needed to confirm the postulated cooperative mechanism
between these two genes. To avoid ascertainment bias,
deletion screening should not be limited to patients with
JPI but should be performed also in patients with less se-
vere phenotypes.
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Web Resources
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
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Bannayan-Riley-Ruvalcaba syndrome, and autoimmune lym-
phoproliferative syndrome)
UCSC Genome Browser (May 2004), http://genome.ucsc.edu/
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Reply to Salviati et al.
To the Editor: In this issue, Salviati and colleagues report
the case of an 8-year-old girl whose mild developmental
delay and dysmorphic features led them to perform a
high-resolution karyotype.1 A 12-Mb deletion located in
10q23 and encompassing the PTEN and BMPR1A loci was
detected. The child presented with rectal bleeding at age
5 years. Colonoscopy at age 6 years uncovered 115 ha-
martomatous polyps throughout the entire colon, allow-
ing the diagnosis of juvenile polyposis (JP). By operational
definition, JP in patients younger than 6 years may be
classified as “JP of infancy.” Thus, the rectal bleeding in
this child at age 5 years was almost certainly due to the
juvenile polyps uncovered only the following year; there-
fore, this case corroborates our report.2 However, the pre-
sentation and the disease course of the patient reported
by Salviati et al.1 were not as severe as those of the four
patients reported in our recent study2 and about which
we hypothesize that the cooperation of the deletions of
both tumor-suppressor genes PTEN and BMPR1A leads to
severe JP and, hence, to cases of JP of infancy. The report
by Salviati and colleagues1 is very interesting, illustrating
that a very large deletion (12 Mb, compared with 2 Mb
in patients 1 and 2 in our report2 and ∼4.8 Mb in the
patient reported by Tsuchiya et al.3) may be, paradoxically,
associated with a less severe disease course than a small
deletion or a point mutation. As proposed by Salviati and
colleagues,1 the protective effect of a modifier allele of a
gene unlinked to the PTEN and BMPR1A genes may ex-
plain this phenomenon even if, at the present time, no
candidate gene is suggested. Another explanation for this
milder phenotype may be the increased expression level
of the PTEN and BMPR1A genes by the remaining allele,
which thus allows correction of the haploinsufficiency.
Indeed, evidence is accumulating that allelic-specific ex-
pression is relatively common among nonimprinted au-
tosomal genes and may be due to cis-acting, genetically
inherited variations.4 Because of the very large size of the
10q22.3-q23 deletion in the patient reported by Salviati
and colleagues,1 we speculate that, without the increased
expression level by the remaining chromosome of some
critical genes other than PTEN and BMPR1A located in the
deleted region, this condition would have been lethal.
Thus, we suggest that the affected child may have some
cis-acting–specific sequences in the remaining allele that
correct the haploinsufficiency in the 10q22.3-q23 region
and lead, paradoxically, to an attenuated phenotype. The
study by Salviati et al.1 illustrates how meticulous analyses
of cases presenting with a similar disease are useful. To-
gether with our original publication, this study should
spur the international community to cooperatively and
systematically study all JP syndrome diagnoses, the fre-
quency of deletion of either or both genes, and their pre-
